A real world, observational, multi-center study for identification of the optimal patients for trifluridine/tipiracil (FTD/TPI) treatment in metastatic colorectal cancer
Latest Information Update: 28 Feb 2020
At a glance
- Drugs Tipiracil/trifluridine (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
Most Recent Events
- 28 Feb 2020 New trial record
- 25 Jan 2020 Results presented at the 2020 Gastrointestinal Cancers Symposium